|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1992-9-17
|
|
pubmed:abstractText |
The immune response to recombinant and plasma-derived vaccines was evaluated in 53 and 43 uremic patients, respectively. The total rate of seroconversion was around 80% with both vaccines, although a significantly higher response was obtained with the protocol using recombinant vaccine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0028-2766
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
328
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1386905-Aged,
pubmed-meshheading:1386905-Female,
pubmed-meshheading:1386905-Hepatitis B Antibodies,
pubmed-meshheading:1386905-Hepatitis B Vaccines,
pubmed-meshheading:1386905-Humans,
pubmed-meshheading:1386905-Male,
pubmed-meshheading:1386905-Middle Aged,
pubmed-meshheading:1386905-Uremia,
pubmed-meshheading:1386905-Vaccines, Synthetic,
pubmed-meshheading:1386905-Viral Hepatitis Vaccines
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Hepatitis B vaccination in uremic patients: comparison between recombinant and plasma-derived vaccine.
|
|
pubmed:affiliation |
Servizio di Nefrologia e Dialisi, Ospedale degli Infermi, Biella, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|
